Literature DB >> 156198

Suppression of acute and chronic inflammation in tumor-bearing rats.

J P Brozna, P A Ward.   

Abstract

Both acute and chronic cellular inflammatory reactions were suppressed in rats bearing malignant tumors. Inhibition of the acute inflammatory reactions was demonstrated in immune complex-induced vasculitis and in the accumulation of leukocytes in subcutaneously implanted polyvinyl sponges. Suppression of chronic inflammatory reactions was demonstrated in delayed type hypersensitivity skin reactions. In spite of these suppressed reactions, dermal reactivity to vasopermeability mediators was not diminished. Neither serum complement levels nor numbers of circulating leukocytes were depressed in animals with tumors. Suppression of inflammatory reactions was paralleled by a leukotactic defect which involved both neutrophils and monocytes. This defect could be ascribed to an abnormality in the serum that rendered both cell types leukotactically defective.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 156198      PMCID: PMC372118          DOI: 10.1172/JCI109452

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  20 in total

1.  A comparative study of the incidence of anergy in patients with carcinoma, leukemia, hodgkin's disease and other lymphomas.

Authors:  D LAMB; F PILNEY; W D KELLY; R A GOOD
Journal:  J Immunol       Date:  1962-10       Impact factor: 5.422

2.  Delayed cutaneous reactions in the rat.

Authors:  M H FLAX; B H WAKSMAN
Journal:  J Immunol       Date:  1962-10       Impact factor: 5.422

3.  High specific activity iodination of gamma-globulin with iodine-131 monochloride.

Authors:  R W HELMKAMP; R L GOODLAND; W F BALE; I L SPAR; L E MUTSCHLER
Journal:  Cancer Res       Date:  1960-11       Impact factor: 12.701

4.  Inflammation and prognosis in breast cancer; a search for host resistance.

Authors:  J W BERG
Journal:  Cancer       Date:  1959 Jul-Aug       Impact factor: 6.860

5.  The inflammatory response to a foreign body within transplantable tumors.

Authors:  M J MAHONEY; J LEIGHTON
Journal:  Cancer Res       Date:  1962-04       Impact factor: 12.701

6.  Serum-associated inhibition of leukotaxis in humans with cancer.

Authors:  E G Maderazo; T F Anton; P A Ward
Journal:  Clin Immunol Immunopathol       Date:  1978-02

7.  Antileukotactic properties of tumor cells.

Authors:  J P Brozna; P A Ward
Journal:  J Clin Invest       Date:  1975-09       Impact factor: 14.808

8.  Suppression of immune complex-induced inflammation by the chemotactic factor inactivator.

Authors:  K J Johnson; T P Anderson; P A Ward
Journal:  J Clin Invest       Date:  1977-05       Impact factor: 14.808

9.  Depression of macrophage function by a factor produced by neoplasms: a merchanism for abrogation of immune surveillance.

Authors:  M C Pike; R Snyderman
Journal:  J Immunol       Date:  1976-10       Impact factor: 5.422

10.  BOUND COMPLEMENT AND IMMUNOLOGIC INJURY OF BLOOD VESSELS.

Authors:  P A WARD; C G COCHRANE
Journal:  J Exp Med       Date:  1965-02-01       Impact factor: 14.307

View more
  3 in total

Review 1.  Effects of tumor growth on host defenses.

Authors:  G J Cianciolo; R Snyderman
Journal:  Cancer Metastasis Rev       Date:  1986       Impact factor: 9.264

2.  Defective neutrophil mobilization to skin chambers in cancer patients.

Authors:  G Frumento; E Bonvini; F Minervini; F Dallegri; F Patrone; C Sacchetti
Journal:  J Cancer Res Clin Oncol       Date:  1984       Impact factor: 4.553

3.  Restoration by ketoprofen of defective neutrophil granulocyte migration induced in guinea-pigs by plasma from cancer patients.

Authors:  J P Bureau; R Senelar; D Cupissol
Journal:  Br J Exp Pathol       Date:  1980-10
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.